Formosa Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	4,061	3,986	5,654	6,700	5,921	3,390
Market Cap Growth	19.56%	-29.51%	-15.62%	13.17%	74.66%	-
Enterprise Value	2,647	2,499	4,017	5,472	5,800	2,937
Last Close Price	26.90	26.40	37.45	49.95	50.59	32.95
PS Ratio	427.73	419.78	39.44	214.95	4502.47	118.82
PB Ratio	2.79	2.74	3.65	5.88	12.67	8.62
P/TBV Ratio	4.08	4.01	4.69	8.77	105.56	-
EV/Sales Ratio	278.78	263.21	28.02	175.53	4410.71	102.95
Debt / Equity Ratio	0.02	0.02	0.02	0.03	0.02	0.01
Net Debt / Equity Ratio	-0.97	-0.97	-1.05	-1.04	-0.89	-0.52
Net Debt / EBITDA Ratio	11.02	11.02	11.57	4.79	1.20	0.60
Net Debt / FCF Ratio	13.39	13.39	11.92	5.99	1.20	0.62
Asset Turnover	0.01	0.01	0.08	0.02	0.00	0.05
Inventory Turnover	3.14	3.14	-	-	-	-
Quick Ratio	8.82	8.82	8.57	4.89	6.26	11.55
Current Ratio	9.11	9.11	8.73	4.99	6.56	12.15
Return on Equity (ROE)	-5.56%	-5.56%	-14.94%	-40.04%	-94.39%	-135.15%
Return on Assets (ROA)	-5.10%	-5.10%	-5.72%	-13.58%	-30.45%	-41.28%
Return on Capital Employed (ROCE)	-9.00%	-9.00%	-9.20%	-19.30%	-47.20%	-56.80%
Earnings Yield	-2.06%	-2.10%	-3.55%	-4.81%	-6.86%	-11.83%
FCF Yield	-2.60%	-2.65%	-2.40%	-2.96%	-5.85%	-9.78%
Buyback Yield / Dilution	-7.22%	-7.22%	-13.48%	-18.00%	-13.70%	-31.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.